Market Capitalization (Millions $) |
236 |
Shares
Outstanding (Millions) |
87 |
Employees |
- |
Revenues (TTM) (Millions $) |
8 |
Net Income (TTM) (Millions $) |
-34 |
Cash Flow (TTM) (Millions $) |
3 |
Capital Exp. (TTM) (Millions $) |
0 |
Compugen Ltd
Compugen Ltd. is a biotechnology company based in Israel. It focuses on the discovery and development of therapeutic drugs and drug targets using a unique predictive computational platform called discovery engine. The company utilizes advanced algorithms to analyze vast amounts of genomic and proteomic data to identify potential drug candidates. Compugen aims to revolutionize the drug discovery and development process by reducing time and cost involved, ultimately leading to the development of innovative therapies for diseases such as cancer, autoimmune disorders, and neurodegenerative diseases.
Company Address: Azrieli Center Holon 5885849
Company Phone Number: 3-765-8585 Stock Exchange / Ticker: NASDAQ CGEN
|